ncRNADetailInformation

Detail Information
Functional analysis

miRNA name

pre-miRNA

family

pre-miRNA Sequence

mature-miRNA

mature sequence

pre-miRNA description

miR-548c-5p

MI0003630	MIPF0000317	CAUUGGCAUCUAUUAGGUUGGUGCAAAAGUAAUUGCGGUUUUUGCCAUUACUUUCAGUAGCAAAAAUCUCAAUUACUUUUGCACCAACUUAAUACUU	MIMAT0004806 hsa-miR-548c-5p	AAAAGUAAUUGCGGUUUUUGCC	Extensive cloning studies suggest that the 5' miRNA may be the predominantone .
MI0003630	MIPF0000317	CAUUGGCAUCUAUUAGGUUGGUGCAAAAGUAAUUGCGGUUUUUGCCAUUACUUUCAGUAGCAAAAAUCUCAAUUACUUUUGCACCAACUUAAUACUU	MIMAT0004806 hsa-miR-548c-5p	AAAAGUAAUUGCGGUUUUUGCC	Extensive cloning studies suggest that the 5' miRNA may be the predominantone .
MI0003630	MIPF0000317	CAUUGGCAUCUAUUAGGUUGGUGCAAAAGUAAUUGCGGUUUUUGCCAUUACUUUCAGUAGCAAAAAUCUCAAUUACUUUUGCACCAACUUAAUACUU	MIMAT0004806 hsa-miR-548c-5p	AAAAGUAAUUGCGGUUUUUGCC	Extensive cloning studies suggest that the 5' miRNA may be the predominantone .
MI0003630	MIPF0000317	CAUUGGCAUCUAUUAGGUUGGUGCAAAAGUAAUUGCGGUUUUUGCCAUUACUUUCAGUAGCAAAAAUCUCAAUUACUUUUGCACCAACUUAAUACUU	MIMAT0004806 hsa-miR-548c-5p	AAAAGUAAUUGCGGUUUUUGCC	Extensive cloning studies suggest that the 5' miRNA may be the predominantone .
MI0003630	MIPF0000317	CAUUGGCAUCUAUUAGGUUGGUGCAAAAGUAAUUGCGGUUUUUGCCAUUACUUUCAGUAGCAAAAAUCUCAAUUACUUUUGCACCAACUUAAUACUU	MIMAT0004806 hsa-miR-548c-5p	AAAAGUAAUUGCGGUUUUUGCC	Extensive cloning studies suggest that the 5' miRNA may be the predominantone .

link to database

TargetScanS 6.2 | MicroCosm | microRNA.org | miRNAMap 2.0

Interacted genes from RAID,miRTarBase

IFT88,BCL2,CTNNB1,BCL2L1
more » IFT88,BCL2,CTNNB1,BCL2L1

KEGG pathways enriched for interacted genes

pathway name

pathway description

target genes enrich in pathway

p-value

hsa05200	Pathways in cancer	BCL2,BCL2L1,CASP3,CTNNB1,	2.66E-4
hsa05014	Amyotrophic lateral sclerosis (ALS)	BCL2,BCL2L1,CASP3,	3.17E-4
hsa05210	Colorectal cancer	BCL2,CASP3,CTNNB1,	8.00E-4
hsa04210	Apoptosis	BCL2,BCL2L1,CASP3,	8.58E-4
hsa05222	Small cell lung cancer	BCL2,BCL2L1,	4.87E-1

Gene ontology terms enriched for interacted genes

GO terms

GO terms description

target genes enrich in GO term

p-value

GO:0034097	response to cytokine stimulus	BCL2,BCL2L1,CASP3,CTNNB1,	7.63E-7
GO:0001836	release of cytochrome c from mitochondria	BCL2,BCL2L1,CASP3,	1.37E-5
GO:0008637	apoptotic mitochondrial changes	BCL2,BCL2L1,CASP3,	3.04E-5
GO:0006915	apoptosis	BCL2,BCL2L1,CASP3,CTNNB1,	3.39E-4
GO:0012501	programmed cell death	BCL2,BCL2L1,CASP3,CTNNB1,	3.54E-4

GO:0014070	response to organic cyclic substance	BCL2,BCL2L1,CTNNB1,	4.70E-4
GO:0010038	response to metal ion	BCL2,BCL2L1,CTNNB1,	5.34E-4
GO:0008219	cell death	BCL2,BCL2L1,CASP3,CTNNB1,	5.74E-4
GO:0010033	response to organic substance	BCL2,BCL2L1,CASP3,CTNNB1,	5.79E-4
GO:0016265	death	BCL2,BCL2L1,CASP3,CTNNB1,	5.86E-4
GO:0007005	mitochondrion organization	BCL2,BCL2L1,CASP3,	6.11E-4
GO:0045165	cell fate commitment	BCL2,CASP3,CTNNB1,	6.20E-4
GO:0042592	homeostatic process	BCL2,BCL2L1,CASP3,CTNNB1,	6.53E-4
GO:0042127	regulation of cell proliferation	BCL2,BCL2L1,CASP3,CTNNB1,	7.50E-4
GO:0007398	ectoderm development	BCL2,CASP3,CTNNB1,	1.26E-2
GO:0009314	response to radiation	BCL2,BCL2L1,CASP3,	1.27E-2
GO:0010035	response to inorganic substance	BCL2,BCL2L1,CTNNB1,	1.34E-2
GO:0007507	heart development	IFT88,CASP3,CTNNB1,	1.47E-2
GO:0035295	tube development	BCL2,IFT88,CTNNB1,	1.54E-2
GO:0060429	epithelium development	BCL2,CASP3,CTNNB1,	1.64E-2
GO:0001782	B cell homeostasis	BCL2,CASP3,	3.24E-2
GO:0051881	regulation of mitochondrial membrane potential	BCL2,BCL2L1,	3.24E-2
GO:0010559	regulation of glycoprotein biosynthetic process	BCL2,CTNNB1,	3.24E-2
GO:0046902	regulation of mitochondrial membrane permeability	BCL2,BCL2L1,	3.24E-2
GO:0043066	negative regulation of apoptosis	BCL2,BCL2L1,CASP3,	3.95E-2
GO:0000902	cell morphogenesis	BCL2,IFT88,CTNNB1,	4.00E-2
GO:0043069	negative regulation of programmed cell death	BCL2,BCL2L1,CASP3,	4.06E-2
GO:0060548	negative regulation of cell death	BCL2,BCL2L1,CASP3,	4.08E-2
GO:0009725	response to hormone stimulus	BCL2,BCL2L1,CTNNB1,	4.24E-2
GO:0009628	response to abiotic stimulus	BCL2,BCL2L1,CASP3,	4.27E-2
GO:0032989	cellular component morphogenesis	BCL2,IFT88,CTNNB1,	4.95E-2
GO:0009719	response to endogenous stimulus	BCL2,BCL2L1,CTNNB1,	5.15E-2
GO:0051402	neuron apoptosis	BCL2,CASP3,	5.60E-2
GO:0043065	positive regulation of apoptosis	BCL2,BCL2L1,CASP3,	5.79E-2
GO:0043068	positive regulation of programmed cell death	BCL2,BCL2L1,CASP3,	5.87E-2
GO:0010942	positive regulation of cell death	BCL2,BCL2L1,CASP3,	5.92E-2
GO:0043029	T cell homeostasis	BCL2,CASP3,	6.19E-2
GO:0048538	thymus development	BCL2,CTNNB1,	6.48E-2
GO:0042733	embryonic digit morphogenesis	IFT88,CTNNB1,	7.37E-2
GO:0033077	T cell differentiation in the thymus	BCL2,CTNNB1,	7.96E-2
GO:0002260	lymphocyte homeostasis	BCL2,CASP3,	8.25E-2
GO:0007006	mitochondrial membrane organization	BCL2,BCL2L1,	9.42E-2

KEGG pathways and Gene Ontology terms enriched for the interacted genes of ncRNA from RAID and miRTarBase.

disease name	related genes	p-value